Investigating the heart risks of flavored e-cigarettes
Cardiac Toxicity of Flavorings in Electronic Nicotine Delivery Systems
This study is looking into how the flavorings in e-cigarettes might affect heart health, especially if they could cause problems with heart rhythm and function, and it's for anyone who uses or is curious about vaping.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Florida NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10919787 on NIH RePORTER |
What this research studies
This research explores the potential cardiac toxicity of flavorings found in electronic nicotine delivery systems (ENDS), particularly focusing on how these flavorings may affect heart health. By using both cell culture techniques and animal models, the study aims to understand the impact of inhaling flavored e-liquids on cardiac function and oxidative stress. The researchers will assess the in-vitro and in-vivo effects of these flavorings, hypothesizing that they may lead to harmful changes in heart rhythm and function.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults and teens who use electronic nicotine delivery systems, particularly those who prefer flavored products.
Not a fit: Patients who do not use electronic nicotine delivery systems or flavored products may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and regulation of flavored e-cigarettes, ultimately improving heart health for users.
How similar studies have performed: While the cardiac effects of traditional tobacco smoking are well-documented, the specific impacts of flavored e-liquids are largely unexplored, making this research a novel investigation.
Where this research is happening
Tampa, United States
- University of South Florida — Tampa, United States (Active)
Researchers
- Principal investigator: Noujaim, Sami Fouad — University of South Florida
- Study coordinator: Noujaim, Sami Fouad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.